These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 23540457)

  • 1. Exploring the Need for Sustained GLP-1 Agonist Therapy: a Perspective on Weight Regain After Bariatric Surgery.
    Chang PC; Huang YW; Huang CK; Chang TW
    Obes Surg; 2024 Jun; 34(6):2259-2260. PubMed ID: 38619774
    [No Abstract]   [Full Text] [Related]  

  • 2. Navigating uncharted waters: long-term implications of GLP-1 agonist use.
    Sher T; Sujka J
    Surg Obes Relat Dis; 2024 May; 20(5):499-500. PubMed ID: 38368200
    [No Abstract]   [Full Text] [Related]  

  • 3. Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol.
    Suleiman N; Alkasem M; Al Amer Z; Salameh O; Al-Thani N; Hamad MK; Baagar K; Abdalhakam I; Othman M; Dughmosh R; Al-Mohanadi D; Al Sanousi A; Bashir M; Chagoury O; Taheri S; Abou-Samra AB
    Trials; 2022 Jun; 23(1):504. PubMed ID: 35710428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and metabolic characteristics of the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) randomised clinical trial cohort.
    Zaghloul H; Chagoury O; Elhadad S; Hayder Ahmed S; Suleiman N; Al Naama A; El Nahas K; Al Hamaq A; Charlson M; Wells MT; Al Abdulla S; Abou-Samra AB; Taheri S
    BMJ Open; 2020 Dec; 10(12):e041386. PubMed ID: 33293319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metabolism in early type 2 diabetes mellitus: study protocol for a randomized controlled trial.
    Taheri S; Chagoury O; Zaghloul H; Elhadad S; Ahmed SH; Omar O; Payra S; Ahmed S; El Khatib N; Amona RA; El Nahas K; Bolton M; Chaar H; Suleiman N; Jayyousi A; Zirie M; Janahi I; Elhag W; Alnaama A; Zainel A; Hassan D; Cable T; Charlson M; Wells M; Al-Hamaq A; Al-Abdulla S; Abou-Samra AB
    Trials; 2018 May; 19(1):284. PubMed ID: 29784059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing postprandial glucose levels in patients with diabetes.
    Tenzer-Iglesias P; Brunton S
    J Fam Pract; 2008 Jan; 57(1 Suppl Managing):S17-24. PubMed ID: 18662529
    [No Abstract]   [Full Text] [Related]  

  • 7. Liraglutide effective in the severely insulin-resistant patient with type 2 diabetes requiring U-500 insulin: a case report.
    Pantalone KM; Faiman C
    Diabetes Technol Ther; 2013 Apr; 15(4):342-3. PubMed ID: 23379638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, type 2 diabetes mellitus, and other comorbidities: a prospective cohort study of laparoscopic sleeve gastrectomy vs medical treatment.
    Leonetti F; Capoccia D; Coccia F; Casella G; Baglio G; Paradiso F; Abbatini F; Iossa A; Soricelli E; Basso N
    Arch Surg; 2012 Aug; 147(8):694-700. PubMed ID: 22508671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GLP-1: a new therapeutic principle for the treatment of type 2 diabetes mellitus].
    Menge BA; Meier JJ; Schmidt WE
    Med Klin (Munich); 2010 Mar; 105(3):163-75. PubMed ID: 20349294
    [No Abstract]   [Full Text] [Related]  

  • 10. Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus.
    Kuhadiya ND; Malik R; Bellini NJ; Patterson JL; Traina A; Makdissi A; Dandona P
    Endocr Pract; 2013; 19(6):963-7. PubMed ID: 23807520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirements.
    Lane W; Weinrib S; Rappaport J
    Diabetes Technol Ther; 2011 May; 13(5):592-5. PubMed ID: 21406014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes: prevention and cure?
    Pierce M
    Br J Gen Pract; 2013 Feb; 63(607):60-1. PubMed ID: 23561656
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment intensification in type 2 diabetes mellitus and obesity.
    Zawiejska A; McAleese J; Yemparala P; Taheri S
    Br J Gen Pract; 2013 Apr; 63(609):182. PubMed ID: 23540457
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.